Renowned Podcast Dawn of Drones To Feature Draganfly
January 03, 2022 07:30 ET | Draganfly Inc
Los Angeles, CA., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and...
Draganfly Selected to Implement Health and Safety Program to Keep Events Safe During CES® 2022
December 30, 2021 07:45 ET | Draganfly Inc
Draganfly’s Vital Intelligence platform continues to provide seamless and non-invasive solutions that are helping organizations host safe events and gatherings Los Angeles, CA., Dec. 30, 2021 ...
Cavitation Technologies, Inc. Releases Letter to Shareholders Providing Corporate Update and Year-End 2021 Results
December 29, 2021 10:00 ET | Cavitation Technologies, Inc
Chatsworth, CA, Dec. 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Cavitation Technologies, Inc. (OTCQB: CVAT), a leading nano-technology fluids processing company, is pleased to release a letter...
globex logo.jpg
Globex’s Mooseland Royalty Gold Property being Acquired by St. Barbara Limited
December 23, 2021 12:17 ET | Globex Mining Enterprises Inc.
ROUYN-NORANDA, Quebec, Dec. 23, 2021 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS...
Woz ED, Imagine Learning’s Robotify and The Drone Racing League Select Draganfly to Expand STEM Program
December 21, 2021 08:00 ET | Draganfly Inc
Woz ED and Imagine Learning’s Robotify with the support of Draganfly to teach thousands of students how to build, code, and fly racing drones in a new “Science of Drone Racing” program New York,...
Basilea receives USD 10 million milestone payment related to approval of antifungal Cresemba® (isavuconazole) in China
December 21, 2021 01:15 ET | Basilea Pharmaceutica AG
Chinese National Medical Products Administration (NMPA) granted Drug Approval License for Cresemba in China to Basilea’s license partner Pfizer Ad hoc announcement pursuant to Art. 53 LR Basel,...
Basilea erhält USD 10 Mio. Meilensteinzahlung aufgrund von Marktzulassung des Antimykotikums Cresemba® (Isavuconazol) in China
December 21, 2021 01:15 ET | Basilea Pharmaceutica AG
Zulassung von Cresemba in China durch Chinesische National Medical Products Administration (NMPA) für Basileas Lizenzpartner Pfizer Ad hoc-Mitteilung gemäss Art. 53 KR Basel, 21. Dezember 2021 ...
GoldQuest: Grant of Stock Options
December 17, 2021 19:21 ET | GoldQuest Mining Corp.
VANCOUVER, British Columbia, Dec. 17, 2021 (GLOBE NEWSWIRE) -- GoldQuest Mining Corp. (TSXV:GQC, “GoldQuest” or the “Company”) announces that the board of directors of the Company has authorized the...
CLC Golden Logo - Full.jpg
Christina Lake Cannabis Corp. Announces Warrant Extension
December 17, 2021 16:53 ET | Christina Lake Cannabis Corp.
VANCOUVER, British Columbia, Dec. 17, 2021 (GLOBE NEWSWIRE) -- (CSE: CLC) Christina Lake Cannabis Corp. (the “Corporation” or “Christina Lake”) announces the extension to the expiry date of a total...
Basilea announces FDA approval of Investigational New Drug application for novel oncology drug candidate BAL0891
December 17, 2021 01:15 ET | Basilea Pharmaceutica AG
Phase 1 study in patients with advanced solid tumors planned to start in the first quarter of 2022 Ad hoc announcement pursuant to Art. 53 LR Basel, Switzerland, December 17, 2021 Basilea...